Dishman Carbogen Amcis Limited
DCALPharmaceuticals
Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
141Announcements
07-09-2026Last filed
20Last 90 days
What Dishman files
- Others56
- Investor Meet24
- Board Meeting17
- Important14
- Updates12
- PPTs10
Showing Results announcements (1)Clear filter
12-02-2025 · 08:17 pm
Dishman Carbogen Amcis has announced a board meeting where it approved the unaudited financial results for the third quarter and nine months ended December 31, 2024. Standalone net loss was ₹13.28 crore, compared to a profit of ₹14.25 crore in the same period last year. Consolidated revenue reached ₹687.97 crore,...